We are live on
!
Find out more
MBE
Michael B. Elefante Portfolio holdings
AUM
$91.5M
Turnover
27.89%
1-Year Est. Return
13.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.45%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$14.3M
(+6.6%)
Cap. Flow
+$10.4M
Cap. Flow
% of AUM
4.51%
Top 10 Holdings %
Top 10 Hldgs %
31.83%
Holding
146
New
35
Increased
57
Reduced
31
Closed
6
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.19M |
| 2 |
Target
TGT
|
+$645K |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$524K |
| 4 |
Fiserv Inc
FISV
|
+$483K |
| 5 |
IPG Photonics
IPGP
|
+$386K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$595K |
| 2 |
Stryker
SYK
|
+$258K |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$228K |
| 4 |
General Mills
GIS
|
+$227K |
| 5 |
COL
Rockwell Collins
COL
|
+$216K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.63% |
| 2 | Healthcare | 23.62% |
| 3 | Industrials | 17.11% |
| 4 | Energy | 10.93% |
| 5 | Miscellaneous | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
National Health Investors
NHI
$3.27B
| $29K | 0.01% |
+485
| New | +$29.4K |
2014 Q1
0 quarters
|
|
127
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $28K | 0.01% |
+560
| New | +$27.1K |
2014 Q1
0 quarters
|
|
128
Cognex
CGNX
$9.31B
| $27K | 0.01% |
+1,600
| New | +$29.9K |
2014 Q1
0 quarters
|
|
|
PBCT
129
DELISTED
People's United Financial Inc
PBCT
| $27K | 0.01% |
+1,800
| New | +$26.2K |
2014 Q1
0 quarters
|
|
|
WIN
130
DELISTED
Windstream Holdings Inc
WIN
| $19K | 0.01% |
+300
| New | +$18.6K |
2014 Q1
0 quarters
|
|
131
Capital One
COF
$120B
| – | – |
-2,480
| Closed | -$190K | – |
|
132
Coca-Cola
KO
$400B
| – | – |
-4,979
| Closed | -$205K | – |
|
|
133
Stryker
SYK
$111B
| – | – |
-3,435
| Closed | -$258K | – |
|
134
Thermo Fisher Scientific
TMO
$254B
| – | – |
-800
| Closed | -$89K | – |
|
135
Tortoise Energy Infrastructure Corp
TYG
$969M
| – | – |
-1,063
| Closed | -$203K | – |
|
|
COL
136
DELISTED
Rockwell Collins
COL
| – | – |
-2,920
| Closed | -$216K | – |
|
Similar funds
AEPI
CC
TM
VNB
ECP
WIL
RCM
ZTNA
Michael B. Elefante's Q1 2014 Portfolio in Review
As of Q1 2014, Michael B. Elefante held 146 positions worth $231M, up 6.6% from $217M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael B. Elefante deployed $10.4M of net new capital in Q1 2014, opening 35 new positions and adding to 57 existing holdings. Its largest new stake was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $595K trimmed.
- Michael B. Elefante's largest Q1 2014 buy was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.
- Michael B. Elefante added most to Qualcomm in Q1 2014, an estimated $1.19M increase.
- Michael B. Elefante's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $595K.
- Michael B. Elefante fully exited Stryker in Q1 2014, selling an estimated $258K.
- Michael B. Elefante's ten largest holdings make up 32% of its $231M portfolio in Q1 2014.
- Michael B. Elefante opened 35 new positions and closed 6 in Q1 2014.
- Michael B. Elefante's portfolio value rose 6.6% quarter-over-quarter to $231M.
Based on Michael B. Elefante's 13F filing for Q1 2014, filed 29 May 2014.